KITLG and neoplasm: Pan et al. demonstrated that mice bearing tumor cells with SCF siRNA exhibited significantly reduced MDSC expansion and restored proliferative responses of tumor-infiltrating T cells, leading to decreased tumor angiogenesis, decreased number of Foxp3+ Tregs, possibly suppressed Th2 responses and enhanced Th1 responses.